Rosetta Genomics to Raise $4.5M Through Direct Offering | GenomeWeb

NEW YORK (GenomeWeb News) – Rosetta Genomics said today that institutional investors have agreed to around $5.1 million in securities through a direct share offering.

The molecular diagnostics developer plans to use the expected $4.5 million in proceeds from the offering for general corporate purposes.

Rosetta said it has agreed to sell an aggregate of 2.5 million of ordinary shares and warrants to purchase up to about 1.3 million more ordinary shares.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.